ACPU
GILD icon

Arrowgrass Capital Partners (US)’s Gilead Sciences GILD Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-157,500
Closed -$9.85M – 354
2018
Q4 		$9.85M Buy
157,500
+155,925
+9,900% +$10.9M 0.37% 86
2018
Q3 		$12.2M Sell
1,575
-155,925
-99% -$11.8M 0.37% 79
2018
Q2 		$11.2M Buy
+157,500
New +$11.1M 0.38% 71
2018
Q1 		– Sell
-112,600
Closed -$8.07M – 267
2017
Q4 		$8.07M Buy
112,600
+111,056
+7,193% +$8.43M 0.08% 254
2017
Q3 		$12.5M Sell
1,544
-2,792
-64% -$213K 0.09% 247
2017
Q2 		$30.7M Sell
4,336
-160
-4% -$10.6K 0.23% 111
2017
Q1 		$30.5M Buy
4,496
+3,070
+215% +$216K 0.31% 79
2016
Q4 		$10.2M Buy
1,426
+895
+169% +$66.5K 0.12% 178
2016
Q3 		$4.2M Buy
+531
New +$43.1K 0.06% 230
2014
Q3 		– Sell
-133,100
Closed -$11M – 329
2014
Q2 		$11M Sell
133,100
-311,800
-70% -$24.3M 0.32% 60
2014
Q1 		$31.5M Buy
444,900
+94,900
+27% +$7.44M 1.24% 25
2013
Q4 		$26.3M Buy
+350,000
New +$24.4M 1.23% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s GILD Position: Q1 2019 in Review

Arrowgrass Capital Partners (US) sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 79,125 shares — an estimated $4.95M sold.

Arrowgrass Capital Partners (US) first reported a position in GILD in Q3 2013 and held it in 12 quarters. The position peaked at $13.9M in Q1 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 79,125 Gilead Sciences shares in Q1 2019, an estimated $4.95M.
  • Arrowgrass Capital Partners (US) first reported a position in Gilead Sciences in Q3 2013 and held it in 12 quarters.
  • Arrowgrass Capital Partners (US)'s Gilead Sciences position peaked at $13.9M in Q1 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2019, filed 15 May 2019.